Farrell Simon - Chief Commercial Officer at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
TRVI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Farrell Simon since 12/22/2023

Holdings reported by Farrell Simon for Trevi Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 45.7K $92.2K $2.02 Jun 20, 2023 Direct
Stock Option (right to buy) 175K Feb 15, 2024 Direct Common Stock

Transactions reported by Farrell Simon for Trevi Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.